Free Trial

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Short Interest Ratio & Short Volume

$27.08 -0.03 (-0.11%)
Closing price 07/25/2025 03:56 PM Eastern
Extended Trading
$27.08 0.00 (0.00%)
As of 07/25/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

First Trust Nasdaq Pharmaceuticals ETF Short Interest Data

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a short interest of 6,200 shares, representing 1.13% of the float (the number of shares available for trading by the public). This marks a -47.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 8,255 shares to cover all short positions.

Current Short Interest
6,200 shares
Previous Short Interest
11,700 shares
Change Vs. Previous Month
-47.01%
Dollar Volume Sold Short
$158.91 thousand
Short Interest Ratio
0.4 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
550,000 shares
Short Percent of Float
1.13%
Today's Trading Volume
1,168 shares
Average Trading Volume
8,255 shares
Today's Volume Vs. Average
14%
Short Selling First Trust Nasdaq Pharmaceuticals ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FTXH Short Interest Over Time

FTXH Days to Cover Over Time

FTXH Percentage of Float Shorted Over Time

First Trust Nasdaq Pharmaceuticals ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20256,200 shares $158.91 thousand -47.0%1.1%0.4 $25.63
6/15/202511,700 shares $305.37 thousand +8.3%2.1%0.8 $26.10
5/31/202510,800 shares $276.36 thousand -10.0%1.3%1 $25.59
5/15/202512,000 shares $298.08 thousand +166.7%2.2%1.1 $24.84
4/30/20254,500 shares $116.08 thousand +1,400.0%N/A0.4 $25.80
4/15/2025300 shares $7.32 thousand -57.1%0.1%0.1 $24.39
3/31/2025700 shares $19.27 thousand +40.0%0.1%0.2 $27.53
3/15/2025500 shares $13.99 thousand -37.5%0.1%0.2 $27.97
2/28/2025800 shares $22.49 thousand +14.3%0.2%0.3 $28.11
2/15/2025700 shares $19.08 thousand -41.7%0.1%0.3 $27.25
1/31/20251,200 shares $33.29 thousand +33.3%N/A0.4 $27.74
1/15/2025900 shares $24.29 thousand -40.0%N/A0.4 $26.99
12/31/20241,500 shares $40.46 thousand +275.0%N/A0.6 $26.97
12/15/2024400 shares $10.92 thousand +100.0%N/A0.1 $27.29
11/30/2024200 shares $5.67 thousand -81.8%N/A0.1 $28.36
11/15/20241,100 shares $29.81 thousand -62.1%N/A0.3 $27.10
10/31/20242,900 shares $81.98 thousand +93.3%N/A0.8 $28.27
10/15/20241,500 shares $43.35 thousand +200.0%N/A0.4 $28.90
9/30/2024500 shares $14.42 thousand +66.7%N/A0.1 $28.84
9/15/2024300 shares $8.76 thousand -66.7%N/A0.1 $29.19
8/31/2024900 shares $26.69 thousand +200.0%N/A0.2 $29.66
8/15/2024300 shares $8.58 thousand -85.0%N/A0.1 $28.59
7/31/20242,000 shares $57.10 thousand +25.0%N/A0.4 $28.55
7/15/20241,600 shares $44.83 thousand No ChangeN/A0.3 $28.02
2/15/20241,000 shares $27.80 thousand -66.7%N/A0.1 $27.80
1/31/20243,000 shares $80.91 thousand -44.4%N/A0.4 $26.97
1/15/20245,400 shares $147.37 thousand +500.0%N/A0.7 $27.29
12/31/2023900 shares $23.95 thousand -35.7%N/A0.1 $26.62
12/15/20231,400 shares $36.65 thousand +1,300.0%N/A0.2 $26.18
11/30/2023100 shares $2.50 thousand -66.7%N/A0 $24.98
11/15/2023300 shares $7.37 thousand +200.0%N/A0 $24.56
10/31/2023100 shares $2.40 thousand -66.7%N/A0 $24.04
10/15/2023300 shares $7.68 thousand +50.0%N/A0 $25.61
9/30/2023200 shares $5.11 thousand -89.5%N/A0 $25.57
9/15/20231,900 shares $50.16 thousand -77.1%N/A0.2 $26.40
8/31/20238,300 shares $223.02 thousand +8,200.0%N/A0.6 $26.87
8/15/2023100 shares $2.71 thousand -66.7%N/A0 $27.05
7/31/2023300 shares $7.96 thousand -66.7%N/A0 $26.54
7/15/2023900 shares $23.42 thousand -76.3%N/A0.1 $26.02
6/30/20233,800 shares $99.52 thousand -28.3%N/A0.3 $26.19
Elon Musk: “This will transform civilization as we know it.” (Ad)

Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.

Click here to see the robot stock that could dominate this revolution
6/15/20235,300 shares $140.82 thousand -15.9%N/A0.6 $26.57
5/31/20236,300 shares $161.03 thousand +6,200.0%N/A0.5 $25.56
5/15/2023100 shares $2.66 thousand -66.7%N/A0 $26.62
4/30/2023300 shares $7.98 thousand -25.0%N/A0 $26.60
4/15/2023400 shares $10.76 thousand -20.0%N/A0 $26.90
3/31/2023500 shares $13.05 thousand +400.0%N/A0 $26.10
3/15/2023100 shares $2.55 thousand -99.0%N/A0 $25.53
2/28/20239,500 shares $249.85 thousand -65.5%N/A0.7 $26.30
2/15/202327,500 shares $749.29 thousand +19.6%N/A2.4 $27.25
1/31/202323,000 shares $633.19 thousand -9.1%N/A2.1 $27.53
1/15/202325,300 shares $707.66 thousand +94.6%N/A2.1 $27.97
12/30/202213,000 shares $356.59 thousand -41.2%N/A0.9 $27.43
12/15/202222,100 shares $612.61 thousand -29.2%N/A1.7 $27.72
11/30/202231,200 shares $874.54 thousand +339.4%N/A2.4 $28.03
11/15/20227,100 shares $190.99 thousand +153.6%N/A0.6 $26.90
10/31/20222,800 shares $74.03 thousand +64.7%N/A0.2 $26.44
10/15/20221,700 shares $41.75 thousand No ChangeN/A0.1 $24.56
9/30/20223,700 shares $88.95 thousand -28.9%N/A0.2 $24.04
9/15/20225,200 shares $130.05 thousand -27.8%N/A0.1 $25.01
8/31/20227,200 shares $179.14 thousand -56.9%N/A0.1 $24.88
8/15/202216,700 shares $445.22 thousand +18.4%N/A0.3 $26.66
7/31/202214,100 shares $373.51 thousand +93.2%N/A0.3 $26.49
7/15/20227,300 shares $194.76 thousand No ChangeN/A0.2 $26.68
2/15/20226,100 shares $156.83 thousand -10.3%N/A2 $25.71
1/31/20226,800 shares $175.30 thousand -13.9%N/A2.2 $25.78
1/15/20227,900 shares $203.43 thousand -16.8%N/A2.5 $25.75
12/31/20219,500 shares $257.07 thousand +4.4%N/A3.4 $27.06
12/15/20219,100 shares $240.06 thousand +810.0%N/A3.5 $26.38
11/30/20211,000 shares $25.47 thousand -23.1%N/A0.4 $25.47
11/15/20211,300 shares $35.10 thousand +44.4%N/A0.3 $27.00
10/29/2021900 shares $23.61 thousand -18.2%N/A0.2 $26.23
10/15/20211,100 shares $28.46 thousand -15.4%N/A0.2 $25.87
9/30/20211,300 shares $33.53 thousand -51.9%N/A0.3 $25.79
9/15/20212,700 shares $69.74 thousand -30.8%N/A0.6 $25.83
8/31/20213,900 shares $104.05 thousand +11.4%N/A0.8 $26.68
8/13/20213,500 shares $93.35 thousand +9.4%N/A1.6 $26.67
7/30/20213,200 shares $84.45 thousand +18.5%N/A1.5 $26.39
7/15/20212,700 shares $69.39 thousand -20.6%N/A1 $25.70
6/30/20213,400 shares $87.99 thousand -71.2%N/A0.9 $25.88
6/15/202111,800 shares $307.63 thousand +35.6%N/A1.8 $26.07
5/28/20218,700 shares $224.44 thousand -3.3%N/A1.1 $25.80
5/14/20219,000 shares $231.32 thousand +20.0%N/A0.8 $25.70
4/30/20217,500 shares $195.21 thousand -40.5%N/A0.6 $26.03
4/15/202112,600 shares $324.39 thousand -44.0%N/A1 $25.75
3/31/202122,500 shares $566.78 thousand -12.5%N/A1.7 $25.19
3/15/202125,700 shares $675.65 thousand +30.5%N/A2.1 $26.29
2/26/202119,700 shares $516.14 thousand -21.2%N/A1.9 $26.20
2/12/202125,000 shares $668.63 thousand -3.9%N/A3.2 $26.75
1/29/202126,000 shares $690.30 thousand +10.2%N/A2.9 $26.55
1/15/202123,600 shares $634.60 thousand No ChangeN/A2.7 $26.89
Elon Musk: “This will transform civilization as we know it.” (Ad)

Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.

Click here to see the robot stock that could dominate this revolution

FTXH Short Interest - Frequently Asked Questions

What is First Trust Nasdaq Pharmaceuticals ETF's current short interest?

Short interest is the volume of First Trust Nasdaq Pharmaceuticals ETF shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 6,200 shares of FTXH short. 1.13% of First Trust Nasdaq Pharmaceuticals ETF's shares are currently sold short. Learn More on First Trust Nasdaq Pharmaceuticals ETF's current short interest.

What is a good short interest percentage for First Trust Nasdaq Pharmaceuticals ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.13% of First Trust Nasdaq Pharmaceuticals ETF's floating shares are currently sold short.

Is First Trust Nasdaq Pharmaceuticals ETF's short interest increasing or decreasing?

First Trust Nasdaq Pharmaceuticals ETF saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 6,200 shares, a drop of 47.0% from the previous total of 11,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does First Trust Nasdaq Pharmaceuticals ETF's short interest compare to its competitors?

1.13% of First Trust Nasdaq Pharmaceuticals ETF's shares are currently sold short. Here is how the short interest of companies compare to First Trust Nasdaq Pharmaceuticals ETF: JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (4.12%), Invesco Nasdaq Biotechnology ETF (0.32%), ProShares Ultra Nasdaq Biotechnology (0.57%), Invesco Dorsey Wright Healthcare Momentum ETF (0.25%), VanEck Biotech ETF (0.18%), VanEck Pharmaceutical ETF (41.19%), and iShares Biotechnology ETF (29.39%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short First Trust Nasdaq Pharmaceuticals ETF stock?

Short selling FTXH is an investing strategy that aims to generate trading profit from First Trust Nasdaq Pharmaceuticals ETF as its price is falling. FTXH shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against First Trust Nasdaq Pharmaceuticals ETF?

A short squeeze for First Trust Nasdaq Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FTXH, which in turn drives the price of the stock up even further.

How often is First Trust Nasdaq Pharmaceuticals ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTXH, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:FTXH) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners